FDA Approves New Treatment Option for Rare Anemia FDA Approves New Treatment Option for Rare Anemia

Pegcetacoplan (Empaveli) injection has been approved for use in adults with paroxysmal nocturnal hemoglobinuria (PNH).FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news